Company Performance: Revenue growth, profitability, and successful drug development updates significantly impact investor confidence and drive the stock price.

Market Sentiment: Overall market trends, investor risk appetite, and sector-specific news (e.g., biotech) influence buying and selling pressure on CUV.AU.

Clinical Trial Results: Positive clinical trial data for CUV's drug candidates typically leads to share price increases, while negative results can have the opposite effect.

Regulatory Approvals: Approval of CUV's drugs by regulatory bodies (e.g., FDA) is a major catalyst for stock appreciation.

Partnerships/Acquisitions: Strategic partnerships, licensing deals, or potential acquisition offers can boost the stock price.

Competition: The competitive landscape within the pharmaceutical industry and the emergence of rival drugs affect CUV.AU.

Economic Factors: Broader economic conditions, interest rates, and inflation can indirectly affect investor sentiment and valuation of growth stocks like CUV.